Atlas Trials

The Effect of Empagliflozin and Metformin on Oxidative Capacity and Microvascular Reactivity of Skeletal Muscle in Patients With Type 2 Diabetes Mellitus

Clinical trial NCT07771010 · RECRUITING

Trial details

NCT number
NCT07771010
Sponsor
University Medical Centre Ljubljana
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetes Type 2
Start date
2026-04-16
Primary completion
2027-12-31
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.